Levetiracetam 250 mg Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Levetiracetam 250 mg Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: AED Starting Dose
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Levetiracetam 250 mg Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Levetiracetam 250 mg Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Levetiracetam 250 mg Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Levetiracetam 250 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Initial titration of Levetiracetam
- Adolescent epilepsy
- Older children
- Renal-impaired patients (reduced dose)
Mechanism of Action
Levetiracetam binds to synaptic vesicle protein SV2A, modulating presynaptic neurotransmitter release. Unique mechanism distinct from older AEDs — no significant CYP450 interactions, linear pharmacokinetics, minimal protein binding. Broad-spectrum AED for partial and primary generalised seizures.
Dosage & Administration
- Adults: starting 250 mg twice daily, titrate to 500–1000 mg twice daily.
Side Effects
- Somnolence, asthenia, dizziness, irritability/behavioural changes (especially children).
- Rare suicidal ideation.
Contraindications
- Hypersensitivity, severe renal impairment (dose adjust).
- Caution in psychiatric history.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Levetiracetam 250 mg Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Blister)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Levetiracetam 250 mg Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Levetiracetam 250 mg Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Levetiracetam 250 mg Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Levetiracetam 250 mg Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Levetiracetam 250 mg Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Levetiracetam 250 mg Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Levetiracetam 250 mg Tablet?
Available pack sizes include: 10 x 10 (Blister).
What is the MRP / trade price for Levetiracetam 250 mg Tablet?
MRPs range from ₹705 to ₹705 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Levetiracetam 250 mg Tablet?